Colombian Hospital Pioneers Minimally Invasive Breast Biopsy Technique
A new, highly precise magnetic resonance-guided breast biopsy is now available in Colombia, offering a significant advancement in early cancer detection for women in the country’s eastern region. The International Hospital of Colombia (HIC), through its cardiovascular institute in Floridablanca, is the first medical center in the Colombian East to offer this cutting-edge procedure, eliminating the need for patients to travel to major cities like Bogotá for diagnosis.
Addressing a Critical Gap in Healthcare Access
For years, women in eastern Colombia faced significant barriers to accessing advanced diagnostic tools for breast cancer. Previously, individuals requiring a resonance biopsy – a procedure crucial for diagnosing injuries undetectable by traditional mammography or ultrasound – were forced to seek care in distant urban centers. “We are pioneers in providing this alternative,” a specialist explained. “Many women could not access a resonance biopsy and ended up undergoing unnecessary surgeries. With this new technology, they have the possibility of doing so in an outpatient, fast and safe way, near their homes.”
Streamlined Process and Coverage
The procedure is now included in the country’s Health Benefits Plan (PBS), making it more accessible to a wider population. According to HIC, patients can obtain authorization through their healthcare provider (EPS) and schedule appointments by contacting the Institute directly at (607) 639555 or 3176352208. This streamlined process aims to reduce delays and improve patient outcomes.
Regional Impact and Global Context
The availability of this technology is particularly impactful for Santander, a department with one of the highest rates of breast cancer incidence in Colombia. Providing local access to early diagnosis is expected to alleviate the financial and logistical burdens associated with traveling for medical care. Globally, breast cancer remains a leading health concern for women. According to the Global Cancer Observatory (Globocan), in 2022, it was the most diagnosed cancer in women worldwide, accounting for approximately 13% of all prevalent cases and representing the primary cause of cancer-related deaths among women.
Understanding the Resonance-Guided Biopsy
The resonance-guided biopsy is a minimally invasive procedure performed on an outpatient basis, leaving virtually no visible scars. The technique utilizes a specialized, thick-cut needle equipped with a vacuum system to collect a substantial breast tissue sample, ensuring greater diagnostic precision without the need for surgical intervention.
Beyond the technical advancements, HIC has prioritized patient comfort during the exam. The hospital has created a relaxing environment with soft lighting and calming music to help reduce anxiety.
The Importance of Proactive Breast Health
While this new tool represents a significant step forward, specialists at HIC emphasize that early detection begins with self-awareness. “Resonance biopsy is indicated in specific cases, but self-examination continues to be a key tool to identify alert signals and consult in time,” concluded Dr. Gómez Cruz. Regular monthly self-examinations, routine medical consultations, and annual mammography starting at age 40 remain fundamental to saving lives.
